Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
Data Policies
EDITORIAL
Autoimmune Pulmonary Alveolar Proteinosis: “The Sleeping Beauty and the Kissing Drug”
1
2nd Pulmonary Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, Greece
2
2nd Department of Internal Medicine, “Attikon” General University Hospital, Medical School, University of Athens, Greece
3
7th Pulmonary Department and Asthma Center, Athens Chest Hospital, Greece
4
6th Pulmonary Department, Athens Chest Hospital, Greece
5
1st Pulmonary Department, Athens Chest Hospital, Athens Medical School, National and Kapodistrian University of Athens, Greece
6
Hauner Children’s University Hospital, Ludwig-Maximilians-University, Member of the German Center for Lung Research, Munich, Germany
Corresponding author
Spyros A. Papiris
2nd Pulmonary Medicine Department, “Attikon” University Hospital, 1 Rimini Street, 12462, Haidari, Greece
2nd Pulmonary Medicine Department, “Attikon” University Hospital, 1 Rimini Street, 12462, Haidari, Greece
Pneumon 2014;27(3):202–203
REFERENCES (17)
1.
Trapnell B, Whitsett J, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003;349:2527-39.
2.
Seymour JF, Presneill JJ. Pulmonary Alveolar Proteinosis. Progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215-35.
3.
Trapnell BC, Carey BC, Uchida K, Suzuki T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GMCSF stimulation of macrophages. Curr Opin Immunol 2009;21:514-21.
4.
Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony stimulating factor in pulmonary homeostasis. Science 1994;264:713-6.
5.
Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony stimulating factor deficient mice show no major perturbation of hemopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994;91:5592-6.
6.
Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic Pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte macrophage colony stimulating factor. J Exp Med 1999;190:875-80.
7.
Sakagami T, Uchida K, Suzuki T, et al. Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med 2009;361:2679-81.
8.
Seymour JF, Dunn AR, Vincent JM, Presneill JJ, Pain MC. Efficacy of Granulocyte–Macrophage Colony- Stimulating Factor in acquired alveolar Proteinosis N Engl J Med 1996;335:1924-5.
9.
Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK. Exogenous granulocyte-macrophage stimulating factor in acquired alveolar proteinosis. Am J Respir Crit Care Med 2000;161:1143-8.
10.
Seymour JF, Presneill JJ, Schoch OD, et al. Therapeutic efficacy of granulocyte-macrophage colony stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001;163:524-31.
11.
Venkateshiah SB, Yan SB, Bonfield TL, et al. An open label trial of granulocyte-macrophage stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 2006;130:227-37.
12.
Wylam ME, Ten RM, Katzmann JA, Clawson M, Prakash UBS, Anderson PM. Aerosolized GM-CSF improves pulmonary function in idiopathic pulmonary alveolar proteinosis [abstract]. Am J Respir Crit Care Med 2000;161:A889.
13.
Wylam ME, Ten R, Prakash UBS, Nadrous HF, Clawson ML, Anderson PM. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 2006;27:585-93.
14.
Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/macrophage colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2010;181:1345-54.
15.
Griese M, Ripper J, Sibbersen A, et al. Long-term follow-up and treatment of congenital alveolar proteinosis. BMC Pediatr 2011;11:72.
16.
Beccaria M, Luisetti M, Rodi G, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 2004;23:526-31.
17.
Papiris SA, Tsirigotis P, Kolilekas L, et al. Long-term inhaled Granulocyte Macrophage-Colony Stimulating Factor in Autoimmune Pulmonary Alveolar Proteinosis: Effectiveness, safety, lowest-effective dose. Clin Drug Invest 2014;34:553-64.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.